CompaniesDiopsys

Diopsys

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

125

By Phase

NA: 2

By Status

UNKNOWN: 2COMPLETED: 1

Recent Trials

NCT05416268Lead Sponsor
Study to Compare the Diopsys NOVA and LKC RETeval Devices
NACompleted
20 participants
Started: May 4, 2022 · Completed: May 6, 2022
NCT04117022Collaborator
Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG
NAUnknown
45 participants
Started: Sep 1, 2019 · Completed: Dec 1, 2022
NCT02594280Lead Sponsor
Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.
N/AUnknown
60 participants
Started: Feb 15, 2018 · Completed: May 1, 2019
Funding History (1)
D
Mar 24, 2020
Filing
Related Companies
Lumithera
acquired